Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Switzerland

European Research Council grant · Running

Glyco-Dive Structure, mechanism, and small-molecule inhibition of human and parasite oligosaccharyltransferases

Coordinator
Eidgenoessische Technische Hochschule Zuerich, Switzerland
Runs
1 December 2026 to 30 November 2031
Status
Running
EU funding
€2.5m
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101265759

What the project is doing

In the project's own words, from its summary on CORDIS.

The evolution of multicellular eukaryotic organisms correlates with an enormous increase of N- glycosites and N-glycoproteins, which have essential roles in cell-cell communication, organ development, the immune system, and other key functions in ontogenesis. At the core of this process stands oligosaccharyltransferase (OST), the central enzyme in protein N-glycosylation. OST glycosylates proteins that contain short recognition sequons (N-X-S/T) by transferring a well-defined glycan from a glycolipid substrate.

These reactions occur in the endoplasmic reticulum and precede protein folding because most sequons are no longer accepted by OST in the folded protein. To address how one enzyme, OST, can accommodate and process a multitude of acceptor proteins, we will combine structure determination of OST complexes by cryo-EM, chemo-enzymatic substrate synthesis, in vitro and in vivo analyses of the N-glycosylation reaction and output, and molecular modelling in our experimental approach.

Our research strategy is guided by the evolution of OST itself: In contrast to human cells, eukaryotic parasites have reduced the complexity of their N-glycoproteomes. This simplification correlates with a reduced complexity of OST architecture, which contains fewer than the 8 subunits of human OST. We plan to determine the first structures of parasite OST enzymes and compare their in vitro activities to human OST.Based on the structural and functional differences between parasitic and human OST, we will search for specific small-molecule inhibitors of OST as research tools or as therapeutics.

Our studies will provide insight into N-glycoproteome biogenesis, reveal the functional architecture of mammalian and parasite OST enzymes, and facilitate the development of small- molecule OST inhibitors. The tools and methodologies developed will also pave the way for novel biotechnological applications of N-glycoprotein and N-glycopeptide generation through enzymatic in vitro pipelines.

Topics

Who is involved

OrganisationCityCountryRole
Eidgenoessische Technische Hochschule ZuerichZuerichSwitzerlandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI